InVivoMAb Anti-Human CXCL1/NAP-3/GRO-alpha (Iv0085)
Produktgrößen
1 mg
£210,00
VHC40001-1MG
5 mg
£630,00
VHC40001-5MG
25 mg
£1950,00
VHC40001-25MG
Über dieses Produkt
- SKU:
- VHC40001
- Anwendung:
- Block/Inhibit/Neutralise, ELISA
- Buffer:
- 0.94mM Citric acid, 16.7mM Trisodium citrate dihydrate, 6.2% sucrose, pH 6.5,0.01% Tween 80
- translate.label.attr.clone:
- Iv0085
- Klonalität:
- Monoclonal, Recombinant Monoclonal
- Konzentration:
- 1 mg/ml
- Host:
- Human
- Immunogen:
- CXCL1, GROA, GRO1, Neutrophil-activating protein 3, GRO, C-X-C motif chemokine 1, NAP-3, Growth-regulated alpha protein, MGSA, SCYB1, Melanoma growth stimulatory activity, GRO-alpha(1-73)
- Isotyp:
- IgG1, kappa
- Physischer Zustand:
- Liquid
- Reinheit:
- >95%
- Aufreinigung:
- Protein A/G purified from cell culture supernatant.
- Reaktivitäten:
- Human
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- -20[o]C Avoid freeze/thaw cycles., 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Hersteller:
- AntibodySystem
- Typ:
- Antibody: Recombinant Antibodies